Fate Therapeutics completes private placement

Fate Therapeutics Inc. (NASDAQ:FATE), San Diego, Calif. Business: Gene/Cell therapy, Hematology, Cancer Date completed: 2016-08-08 Type: Private placement Raised: $10.3 million Shares: 5.3 million Pri...